Unihealth Hospitals Q2 Results 2026 (FY27) statement: Revenue & Margins
Q2 FY27 results statement: what the company reported on revenue, margins and capex.
Top 10 Healthcare Services companies on management guidance
See the sector's top 10 — free with your mobile number.
Based on Unihealth Hospitals Ltd's Q2 FY27 results statement. The company has not published an earnings-call transcript for this quarter, so figures here are what the results statement reports, not management guidance.
The short version
Revenue from operations for the half year ended 30 September 2026 is Rs. 7,644.45 lakhs, compared to Rs. 6,666.62 lakhs for the half year ended 30 September 2025, indicating a year-on-year increase. EBITDA reported: Rs. 1,270 million with a year-on-year (YoY) growth of 6.3%.
From Unihealth Hospitals Ltd's Q2 FY27 earnings-call transcript · updated 15 Nov 2026.
How did Unihealth Hospitals' revenue grow in the September 2026 quarter?
- Revenue from operations for the half year ended 30 September 2026 is Rs. 7,644.45 lakhs, compared to Rs. 6,666.62 lakhs for the half year ended 30 September 2025, indicating a year-on-year increase.
- Total revenue for the half year ended 30 September 2026 is Rs. 7,778.1 lakhs versus Rs. 6,956.42 lakhs for the corresponding period in 2025.
What happened to Unihealth Hospitals' margins in Q2 FY27?
EBITDA reported: Rs. 1,270 million with a year-on-year (YoY) growth of 6.3%
Locked: what Unihealth Hospitals Ltd said on margins
Also locked on this page: fundraising, order book
Free account, 30 seconds. No card needed.
What capex is Unihealth Hospitals planning?
- UMC Hospitals Private Limited (India): Funded expansion and capital expenditures with Rs.
- Biohealth Limited, Tanzania: Capital expenditure for expansion fully funded; USD 278,000 allocated and fully utilized by Sept 30, 2026.
- Victoria Hospital Limited, Uganda: Capital expenditure and working capital for expansion funded with Rs. 1,700 Lakhs utilized fully.
- UMC Global Health Limited, Nigeria: Capital expenditure for expansion; Rs. 290.30 Lakhs utilized, Rs. 169.70 Lakhs unutilized as of Sept 30, 2026.
2 more points from Unihealth Hospitals Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Is Unihealth Hospitals raising money or cutting debt?
The company raised Rs. 10.57 crores through a preferential issue of 7,00,000 convertible equity warrants…
Locked: what Unihealth Hospitals Ltd said on fundraising
Also locked on this page: margins, order book
Free account, 30 seconds. No card needed.
How big is Unihealth Hospitals' order book?
See what Unihealth Hospitals Ltd said on order book & pipeline — free account, 30 seconds.
More Q2 FY27 results in Healthcare Services
Continue your research
What Unihealth Hosp's management said in earlier quarters
- Q4 FY26 earnings call analysis →
- Q2 FY26 earnings call analysis →
- Q4 FY25 earnings call analysis →
- Q2 FY25 earnings call →
Earlier calls (2)
Others in Healthcare Services this season
- Chandan Healthca (Q2 FY27)
Revenue from operations for the half year ended 30th September 2026 is ₹10,660.84 lakhs, compared to the previous year ended 31st March 2026 figure of…
- Invicta Diagnostic (Q2 FY27)
Revenue from operations for the half year ended September 30, 2026: ₹379.11 lakhs (Page 4). Key results statement takeaways from Invicta Diagnostic Ltd's Q2 FY2
- Sangani Hospital (Q2 FY27)
1008.56 lakhs (~11.8% increase). Key results statement takeaways from Sangani Hospitals Ltd's Q2 FY27 results statement — and how it ranks against sector peers.
- Health X Platform (Q2 FY27)
Q2 FY27 revenue from operations: Rs 489.1 Cr, up 58.8% year-on-year (Page 24). Key investor presentation takeaways from Health X Platform Ltd's Q2 FY27 investor
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- IndegeneGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Unihealth Hospitals Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Unihealth Hospitals Ltd Q2 FY27 results?
Revenue from operations for the half year ended 30 September 2026 is Rs. 7,644.45 lakhs, compared to Rs. 6,666.62 lakhs for the half year ended 30 September 2025, indicating a year-on-year increase. EBITDA reported: Rs. 1,270 million with a year-on-year (YoY) growth of 6.3%.
What is Unihealth Hospitals Ltd share price analysis?
Unihealth Hospitals Ltd currently shows a neutral. The stock trades at a P/E of 33.2 with a market cap of ₹851 Cr. Investors should review the full earnings analysis for detailed insights.
Is Unihealth Hospitals Ltd planning capital expenditure?
UMC Hospitals Private Limited (India): Funded expansion and capital expenditures with Rs.
Keep Unihealth Hospitals Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's results statement. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
